Global cGMP Cell Banking Service 麻豆原创 Research Report 2024

Publication ID:

PB512243282

Publication Date:

December 31, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for cGMP Cell Banking Service was valued at US$ 514 million in the year 2023 and is projected to reach a revised size of US$ 641 million by 2030, growing at a CAGR of 3.3% during the forecast period.
cGMP Cell Banking Service is a cell bank construction and management service that complies with cGMP (Current Good Manufacturing Practice) requirements and is designed to provide high-quality cell storage and production support for the development of biopharmaceuticals and cell therapy products. Through strict operating specifications and quality control, this service provides customers with the construction, validation and long-term storage of Master Cell Bank (MCB) and Working Cell Bank (WCB), ensuring the genetic stability, sterility and reproducibility of cells to meet regulatory and production requirements.
North American market for cGMP Cell Banking Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for cGMP Cell Banking Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for cGMP Cell Banking Service in Biopharmaceuticals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of cGMP Cell Banking Service include Charles River Laboratories, Sartorius, ProBio, Altogen Labs, WuXi Biologics, RoslinCT, Wheeler Bio, uBriGene, ATCC, GBI, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for cGMP Cell Banking Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding cGMP Cell Banking Service.
The cGMP Cell Banking Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global cGMP Cell Banking Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the cGMP Cell Banking Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Charles River Laboratories
Sartorius
ProBio
Altogen Labs
WuXi Biologics
RoslinCT
Wheeler Bio
uBriGene
ATCC
GBI
SK Pharmteco
ExcellGene SA
Northway Biotech
Segment by Type
Master Cell Bank (MCB) Construction
Working Cell Bank (WCB) Construction
Others
Segment by Application
Biopharmaceuticals
Cell and Gene Therapy
Biotechnology R&D
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of cGMP Cell Banking Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global cGMP Cell Banking Service 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Master Cell Bank (MCB) Construction
1.2.3 Working Cell Bank (WCB) Construction
1.2.4 Others
1.3 麻豆原创 by Application
1.3.1 Global cGMP Cell Banking Service 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biopharmaceuticals
1.3.3 Cell and Gene Therapy
1.3.4 Biotechnology R&D
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global cGMP Cell Banking Service 麻豆原创 Perspective (2019-2030)
2.2 Global cGMP Cell Banking Service Growth Trends by Region
2.2.1 Global cGMP Cell Banking Service 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 cGMP Cell Banking Service Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 cGMP Cell Banking Service Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 cGMP Cell Banking Service 麻豆原创 Dynamics
2.3.1 cGMP Cell Banking Service Industry Trends
2.3.2 cGMP Cell Banking Service 麻豆原创 Drivers
2.3.3 cGMP Cell Banking Service 麻豆原创 Challenges
2.3.4 cGMP Cell Banking Service 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top cGMP Cell Banking Service Players by Revenue
3.1.1 Global Top cGMP Cell Banking Service Players by Revenue (2019-2024)
3.1.2 Global cGMP Cell Banking Service Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global cGMP Cell Banking Service 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by cGMP Cell Banking Service Revenue
3.4 Global cGMP Cell Banking Service 麻豆原创 Concentration Ratio
3.4.1 Global cGMP Cell Banking Service 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by cGMP Cell Banking Service Revenue in 2023
3.5 Global Key Players of cGMP Cell Banking Service Head office and Area Served
3.6 Global Key Players of cGMP Cell Banking Service, Product and Application
3.7 Global Key Players of cGMP Cell Banking Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 cGMP Cell Banking Service Breakdown Data by Type
4.1 Global cGMP Cell Banking Service Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global cGMP Cell Banking Service Forecasted 麻豆原创 Size by Type (2025-2030)
5 cGMP Cell Banking Service Breakdown Data by Application
5.1 Global cGMP Cell Banking Service Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global cGMP Cell Banking Service Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America cGMP Cell Banking Service 麻豆原创 Size (2019-2030)
6.2 North America cGMP Cell Banking Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America cGMP Cell Banking Service 麻豆原创 Size by Country (2019-2024)
6.4 North America cGMP Cell Banking Service 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe cGMP Cell Banking Service 麻豆原创 Size (2019-2030)
7.2 Europe cGMP Cell Banking Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe cGMP Cell Banking Service 麻豆原创 Size by Country (2019-2024)
7.4 Europe cGMP Cell Banking Service 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific cGMP Cell Banking Service 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific cGMP Cell Banking Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific cGMP Cell Banking Service 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific cGMP Cell Banking Service 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America cGMP Cell Banking Service 麻豆原创 Size (2019-2030)
9.2 Latin America cGMP Cell Banking Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America cGMP Cell Banking Service 麻豆原创 Size by Country (2019-2024)
9.4 Latin America cGMP Cell Banking Service 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa cGMP Cell Banking Service 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa cGMP Cell Banking Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa cGMP Cell Banking Service 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa cGMP Cell Banking Service 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Details
11.1.2 Charles River Laboratories Business Overview
11.1.3 Charles River Laboratories cGMP Cell Banking Service Introduction
11.1.4 Charles River Laboratories Revenue in cGMP Cell Banking Service Business (2019-2024)
11.1.5 Charles River Laboratories Recent Development
11.2 Sartorius
11.2.1 Sartorius Company Details
11.2.2 Sartorius Business Overview
11.2.3 Sartorius cGMP Cell Banking Service Introduction
11.2.4 Sartorius Revenue in cGMP Cell Banking Service Business (2019-2024)
11.2.5 Sartorius Recent Development
11.3 ProBio
11.3.1 ProBio Company Details
11.3.2 ProBio Business Overview
11.3.3 ProBio cGMP Cell Banking Service Introduction
11.3.4 ProBio Revenue in cGMP Cell Banking Service Business (2019-2024)
11.3.5 ProBio Recent Development
11.4 Altogen Labs
11.4.1 Altogen Labs Company Details
11.4.2 Altogen Labs Business Overview
11.4.3 Altogen Labs cGMP Cell Banking Service Introduction
11.4.4 Altogen Labs Revenue in cGMP Cell Banking Service Business (2019-2024)
11.4.5 Altogen Labs Recent Development
11.5 WuXi Biologics
11.5.1 WuXi Biologics Company Details
11.5.2 WuXi Biologics Business Overview
11.5.3 WuXi Biologics cGMP Cell Banking Service Introduction
11.5.4 WuXi Biologics Revenue in cGMP Cell Banking Service Business (2019-2024)
11.5.5 WuXi Biologics Recent Development
11.6 RoslinCT
11.6.1 RoslinCT Company Details
11.6.2 RoslinCT Business Overview
11.6.3 RoslinCT cGMP Cell Banking Service Introduction
11.6.4 RoslinCT Revenue in cGMP Cell Banking Service Business (2019-2024)
11.6.5 RoslinCT Recent Development
11.7 Wheeler Bio
11.7.1 Wheeler Bio Company Details
11.7.2 Wheeler Bio Business Overview
11.7.3 Wheeler Bio cGMP Cell Banking Service Introduction
11.7.4 Wheeler Bio Revenue in cGMP Cell Banking Service Business (2019-2024)
11.7.5 Wheeler Bio Recent Development
11.8 uBriGene
11.8.1 uBriGene Company Details
11.8.2 uBriGene Business Overview
11.8.3 uBriGene cGMP Cell Banking Service Introduction
11.8.4 uBriGene Revenue in cGMP Cell Banking Service Business (2019-2024)
11.8.5 uBriGene Recent Development
11.9 ATCC
11.9.1 ATCC Company Details
11.9.2 ATCC Business Overview
11.9.3 ATCC cGMP Cell Banking Service Introduction
11.9.4 ATCC Revenue in cGMP Cell Banking Service Business (2019-2024)
11.9.5 ATCC Recent Development
11.10 GBI
11.10.1 GBI Company Details
11.10.2 GBI Business Overview
11.10.3 GBI cGMP Cell Banking Service Introduction
11.10.4 GBI Revenue in cGMP Cell Banking Service Business (2019-2024)
11.10.5 GBI Recent Development
11.11 SK Pharmteco
11.11.1 SK Pharmteco Company Details
11.11.2 SK Pharmteco Business Overview
11.11.3 SK Pharmteco cGMP Cell Banking Service Introduction
11.11.4 SK Pharmteco Revenue in cGMP Cell Banking Service Business (2019-2024)
11.11.5 SK Pharmteco Recent Development
11.12 ExcellGene SA
11.12.1 ExcellGene SA Company Details
11.12.2 ExcellGene SA Business Overview
11.12.3 ExcellGene SA cGMP Cell Banking Service Introduction
11.12.4 ExcellGene SA Revenue in cGMP Cell Banking Service Business (2019-2024)
11.12.5 ExcellGene SA Recent Development
11.13 Northway Biotech
11.13.1 Northway Biotech Company Details
11.13.2 Northway Biotech Business Overview
11.13.3 Northway Biotech cGMP Cell Banking Service Introduction
11.13.4 Northway Biotech Revenue in cGMP Cell Banking Service Business (2019-2024)
11.13.5 Northway Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Charles River Laboratories
Sartorius
ProBio
Altogen Labs
WuXi Biologics
RoslinCT
Wheeler Bio
uBriGene
ATCC
GBI
SK Pharmteco
ExcellGene SA
Northway Biotech

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.